Artificial Intelligence | Machine Learning | Natural Language Processing Deciphex | Transforming Pathology


Enterprise, Digital Pathology, Digital Pathology Workflow, Artificial Intelligence, Cloud Dublin , Ireland

Deciphex

Artificial Intelligence | Machine Learning | Natural Language Processing


Deciphex | Transforming Pathology

Deciphex

Digital Pathology, Digital Pathology Workflow, Artificial Intelligence, Cloud


Dublin , Ireland

Deciphex is accelerating pathology service delivery. Pathology is an integral part of health service delivery, it touches 95% of clinical care pathways. There is a growing supply-demand dynamic in global pathology services. A crunch point is developing due to increasing test volumes, increasing test complexity, and flat to declining pathologist numbers. The use of digital pathology (workload balancing) and artificial intelligence (process acceleration) will be a critical part of the solution for shortfalls in pathology services. Deciphex plans to be at the forefront of this revolution, networking with Pathologists from all corners of the globe to drive high-quality, efficient reporting, all while addressing the pathology productivity gap with digital pathology and AI.

Patholytix is the industry-leading digital pathology workflow & integrated AI platform for Research Pathology. Patholytix is trusted by the leading CROs and pharmaceutical companies for handling high volume drug safety pathology studies, providing a complete GLP-compliant workflow with integrated AI screening capabilities. Diagnexia is an online clinical pathology department that provides on-demand access to remote subspecialty pathologists for primary diagnostics and secondary consult services, supporting the acceleration of diagnostic turnaround times and delivery of the highest quality of patient care.

 
 

   Total Funding: N/A

   Funding Stage: N/A

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 51 to 100

   Founded: 2017

May 2022

  • Deciphex Launched Fully Outsourced AI Services
 
 

Date

Round

$ Raised

Investors

01/25/2023

Series B

$4.25M

Seroba Life Sciences

Date : 01/25/2023

Round: Series B

$ Raised: $4.25M

Investors: Seroba Life Sciences

05/19/2022

Series B

$11.5M

Act Venture Capital, Charles River Laboratories, Novartis

Date : 05/19/2022

Round: Series B

$ Raised: $11.5M

Investors: Act Venture Capital, Charles River Laboratories, Novartis

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Deciphex

 
 
 
Donal O'Shea

Donal O'Shea
Chief Executive

Mairin Rafferty

Mairin Rafferty
Chief Operations Officer

Mark Gregson

Mark Gregson
Chief Technology Officer

John Nolan

John Nolan
Chief Commercial Officer

 
 

Deciphex is growing. Want to work at Deciphex? Deciphex is hiring. Join team at Deciphex

 
 
appengine.ai

World's Most Promising AI/ML Startups